Absci logo

Absci

absci.com

Absci uses generative AI and an integrated drug creation platform to design and optimize biologic drugs, including antibodies, for pharmaceutical companies and patients. Its technology combines AI-driven de novo design, lead optimization, and wet lab validation to create therapeutics against difficult-to-drug targets, aiming to accelerate the development of better biologics for challenging diseases.

Facts

HQ
Vancouver, Wash.
Sectors
Biotechnology Research
Founded
2011
Employees
159
Stage
Public
Members see funding amounts.
.

Is this your organization? Claim it

Founders

  • Sean McClain Founder, CEO & Director
  • Sean McClain CEO and Founder
  • Sean McClain Founder and CEO
  • Sean McClain CEO and Founder

Executives

  • Zach Jonasson Executive, Chief Financial Officer & Chief Business Officer

Online